During the past decade, Xiyuan Hospital, CACMS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Xiyuan Hospital, CACMS" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Tianjin TongRenTang Group Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Xiyuan Hospital, CACMS" are "Glomerulonephritis" (1 trials), "Peripheral Artery Disease" (1 trials), "Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts" (1 trials) and "Proteinuria" (1 trials). Many other conditions were trialed in "Xiyuan Hospital, CACMS" in a lesser frequency.

Most popular intervention types in "Xiyuan Hospital, CACMS" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "FG-4592" (1 trials), "Losartan potassium 100mg" (1 trials), "Losartan potassium 50mg" (1 trials), "Placebo" (1 trials) and "Shenyankangfu tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Xiyuan Hospital, CACMS" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Xiyuan Hospital, CACMS". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Xiyuan Hospital, CACMS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Xiyuan Hospital, CACMS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".